OVARIAN STIMULATION

Women's Health
3
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

M&
Merck & Co.RAHWAY, NJ
1 program
1
r-FSHPhase 21 trial
Active Trials
NCT01112358CompletedEst. Jan 2007
IBSA Institut Biochimique
IBSA Institut BiochimiqueSwitzerland - Lugano-Pazzallo
2 programs
2
Gonadotropins SubcutaneosPhase 11 trial
Gonadotropins SubcutaneousPhase 11 trial
Active Trials
NCT06781957CompletedEst. Jan 2026
NCT06659692CompletedEst. Aug 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Merck & Co.r-FSH
IBSA Institut BiochimiqueGonadotropins Subcutaneous
IBSA Institut BiochimiqueGonadotropins Subcutaneos

Clinical Trials (3)

NCT01112358Merck & Co.r-FSH

Lutropin Alfa in Women at Risk of Poor Response

Start: Dec 2005Est. completion: Jan 2007
Phase 2Completed
NCT06659692IBSA Institut BiochimiqueGonadotropins Subcutaneous

Pharmacokinetics of FSH and hCG Following Multiple Dose of Gonadotropins-IBSA.

Start: Oct 2024Est. completion: Aug 2025
Phase 1Completed
NCT06781957IBSA Institut BiochimiqueGonadotropins Subcutaneos

Pharmacokinetics of FSH and hCG After a Single Subcutaneous Injection of Gonadotropins-IBSA

Start: Sep 2024Est. completion: Jan 2026
Phase 1Completed

Related Jobs in Women's Health

Senior Medical Science Liaison

Ferring Pharmaceuticals
Bangkok, Thailand
Yesterday

Senior Key Account Manager

Ferring Pharmaceuticals
Bucureşti, Romania
1w ago

Territory Representative - Miami

Caldera Medical
Miami, FL, US
1w ago

Senior Client Solutions Manager

Progyny
New York, New York
1w ago
$85K - $95K/yr

Sales Representative, Women's Health - Charleston, SC

Viatris (2)
Remote
1w ago
$72K - $108K/yr

Sales Representative Gynecological Health

Medtronic
Malaga, Andalucia, Spain
1w ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

Related Indications

Endometriosis(43)Menopause(27)Polycystic Ovary Syndrome(14)Postmenopause(8)Controlled Ovarian Stimulation(5)Vasomotor Symptoms Associated With Menopause(4)Polycystic Ovarian Syndrome(3)Preeclampsia(3)Uterine Fibroids(3)Uterine Leiomyomata (Fibroids)(3)